Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2025)

Vivos Therapeutics (VVOS) has disclosed Prepaid Assets for 7 consecutive years, with $565000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets fell 10.88% to $565000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $565000.0, a 10.88% decrease, with the full-year FY2024 number at $783000.0, up 27.11% from a year prior.
  • Prepaid Assets was $565000.0 for Q3 2025 at Vivos Therapeutics, down from $695000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.3 million in Q1 2022 to a low of $475000.0 in Q1 2024.
  • A 5-year average of $1.1 million and a median of $927627.0 in 2021 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: skyrocketed 143.09% in 2022, then plummeted 64.71% in 2024.
  • Vivos Therapeutics' Prepaid Assets stood at $1.6 million in 2021, then dropped by 8.06% to $1.4 million in 2022, then crashed by 57.46% to $616000.0 in 2023, then rose by 27.11% to $783000.0 in 2024, then dropped by 27.84% to $565000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Prepaid Assets are $565000.0 (Q3 2025), $695000.0 (Q2 2025), and $547000.0 (Q1 2025).